We are live on ! Find out more
NVCR icon

NovoCure
NVCR

128 hedge funds and large institutions have $778M invested in NovoCure in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

352% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $4.46M

240% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 10

54% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 28

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

23% more funds holding

Funds holding: 104 → 128 (+24)

4% more capital invested

Capital invested by funds: $746M → $778M (+$31.9M)

0.87% more ownership

Funds ownership: 42.2% → 43.07% (+0.87%)

Holders
128
Holders Change
+24
Holders Change %
+23.08%
% of All Funds
2.9%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
34
Increased
43
Reduced
28
Closed
10
Calls
$20.2M
Puts
$4.46M
Net Calls
+$15.7M
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$22.4M
2
WRF
Waddell & Reed Financial
Kansas
+$17M
3
GPP
Great Point Partners
Connecticut
+$13.5M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$11.6M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$92.1M
2
PC
PointState Capital
New York
-$14.9M
3
AC
Ascend Capital
California
-$13M
4
LCM
Laurion Capital Management
New York
-$9.29M
5
JG
Jefferies Group
New York
-$6.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
51
A.R.T. Advisors
New York
$1.58M -$347K -18,000 -19%
AllianceBernstein
52
AllianceBernstein
Tennessee
$1.55M – – –
LCM
53
Laurion Capital Management
New York
$1.51M -$9.29M -482,220 -87%
Swiss National Bank
54
Swiss National Bank
Switzerland
$1.49M – – –
Ameriprise
55
Ameriprise
Minnesota
$1.47M +$269K +13,960 +24%
Macquarie Group
56
Macquarie Group
Australia
$1.42M +$378K +19,606 +39%
EGM
57
Engineers Gate Manager
New York
$1.37M +$875K +45,438 +202%
D.E. Shaw & Co
58
D.E. Shaw & Co
New York
$1.33M +$1.27M +65,925 New
Wells Fargo
59
Wells Fargo
California
$1.33M -$4.03K -209 -0.3%
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$1.25M – – –
Stifel Financial
61
Stifel Financial
Missouri
$1.21M -$569K -29,540 -33%
ProShare Advisors
62
ProShare Advisors
Maryland
$1.15M +$50.5K +2,620 +5%
RhumbLine Advisers
63
RhumbLine Advisers
Massachusetts
$1.12M -$199K -10,319 -16%
CS
64
Credit Suisse
Switzerland
$1.03M -$302K -15,664 -23%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$911K +$2.7K +140 +0.3%
Principal Financial Group
66
Principal Financial Group
Iowa
$823K +$785K +40,743 New
AIG
67
American International Group
New York
$786K +$3.54K +184 +0.5%
IR
68
Invictus RG
Bermuda
$784K +$748K +38,836 New
EMG
69
ETF Managers Group
New Jersey
$696K +$172K +8,929 +35%
SEC
70
Seven Eight Capital
New York
$679K +$647K +33,600 New
GAM
71
Gotham Asset Management
New York
$676K -$64.6K -3,357 -9%
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$597K – – –
GCP
73
GSA Capital Partners
United Kingdom
$568K +$77K +4,000 +17%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$541K – – –
PCM
75
Prelude Capital Management
New York
$538K +$331K +17,173 +182%
1 2
3
4 5

NVCR Hedge Fund Activity: Q4 2017 in Review

128 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2017, worth a combined $778M — up 4.3% from $746M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVCR positions and 10 closed out — a net gain of 24 holders — while 43 added to existing stakes and 28 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $22.4M. The largest seller was Goldman Sachs, cutting an estimated $92.1M.

  • 128 institutional investors held NovoCure (NVCR) as of Q4 2017, up from 104 in Q3 2017.
  • Funds reported $778M of NovoCure stock for Q4 2017, up 4.3% quarter-over-quarter.
  • 34 funds opened new NovoCure positions in Q4 2017 and 10 closed out, a net change of +24 holders.
  • The largest NovoCure buyer in Q4 2017 was Farallon Capital Management, an estimated $22.4M added.
  • The largest NovoCure seller in Q4 2017 was Goldman Sachs, an estimated $92.1M sold.

Based on aggregated 13F filings for Q4 2017.